1849 Bio is a biotechnology company specializing in the development of engineered microbes to enhance copper extraction from low-grade ores. By integrating advanced bioengineering techniques, 1849 Bio offers mining operations a sustainable and efficient solution to unlock the value trapped in stockpiled ores without disrupting existing processes. Key Features and Functionality: - Custom-Engineered Microbes: Tailored microorganisms designed to target specific ore compositions, particularly challenging ores like chalcopyrite. - High Copper Recovery Rates: Achieves up to 60% copper recovery, significantly surpassing the 20% typically obtained through conventional bioleaching methods. - Seamless Integration: Solutions are designed to work within existing leaching infrastructure, ensuring minimal operational disruption. - Comprehensive Process: From analyzing ore samples to deploying optimized microbial solutions, 1849 Bio offers a full-spectrum approach to enhance metal extraction. Primary Value and User Solutions: 1849 Bio addresses the mining industry's challenge of extracting copper from low-grade ores, which traditional methods find unprofitable. By leveraging custom-engineered microbes, the company enables mining operations to efficiently and sustainably extract copper, thereby unlocking significant economic value from existing stockpiles. This approach not only enhances profitability but also promotes environmental sustainability by reducing the need for new mining operations.